Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis
IntroductionVasomotor symptoms, or hot flashes, are among the most common complaints for menopausal and postmenopausal women. As an alternative to hormone replacement therapy, paroxetine mesylate became the only non-hormonal treatment approved by the U.S. Food and Drug Administration (FDA), despite...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2023-08-01
|
| Serie: | Frontiers in Psychiatry |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1204163/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|